Contract 75F40122C00161
Safe Health Systems, Inc. · Department Of Health And Human Services · September 27, 2022
Safe Health Systems, Inc. was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 27, 2022 for $3.79 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 19, 2025. If all options are exercised, the contract could reach $9.67 million.
Contract details
- PIID
- 75F40122C00161
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Silver Spring, MD
- First action
- September 27, 2022
- Latest action
- September 19, 2025
Description
STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOME.
Modification timeline
-
September 19, 2025Mod P00004 · Other Administrative Action$9.67M
-
September 17, 2025Mod P00003 · Other Administrative Action$9.67M
-
September 27, 2022Base award$9.67M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122C00161?
Contract 75F40122C00161 is a federal contract awarded to Safe Health Systems, Inc. by Department Of Health And Human Services on September 27, 2022 for $3.79 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75F40122C00161?
Safe Health Systems, Inc. won contract 75F40122C00161 from Department Of Health And Human Services.
How much is contract 75F40122C00161 worth?
Contract 75F40122C00161 has obligated $3.79 million to date, with a total potential value of $9.67 million if all options are exercised.